메뉴 건너뛰기




Volumn 13, Issue 8, 2013, Pages 814-828

Small molecule inhibitors of multidrug resistance gene (MDR1) expression: Preclinical evaluation and mechanisms of action

Author keywords

Cancer; Downregulators; Gene expression regulation; MDR1 gene; Multidrug resistance; P glycoprotein; Transcription regulation

Indexed keywords

BORTEZOMIB; CELECOXIB; COBALAMIN; CURCUMIN; CYCLOSPORIN; DORAMECTIN; DOXORUBICIN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE INHIBITOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METFORMIN; MILBEMYCIN A; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN; NEMADECTIN; PERIFOSINE; PROMETHAZINE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; PUERARIN; TRABECTEDIN; TRIFLUOPERAZINE; UNINDEXED DRUG; VALSPODAR; VASCULOTROPIN; VERAPAMIL; VINBLASTINE; Y BOX BINDING PROTEIN 1;

EID: 84888108917     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/15680096113139990082     Document Type: Article
Times cited : (17)

References (111)
  • 1
    • 84862522237 scopus 로고    scopus 로고
    • (accessed February 24
    • o 297. http://www. who. int/mediacenter/factsheets/fs297/en/(accessed February 24, 2012).
    • (2012) Fact Sheet
  • 2
    • 78649284256 scopus 로고    scopus 로고
    • Overcoming drug resistance by regulating nuclear receptors
    • Chen, T. Overcoming drug resistance by regulating nuclear receptors. Adv. Drug Deliv. Rev. 2010, 62 (13), 1257-1264.
    • (2010) Adv. Drug Deliv. Rev , vol.62 , Issue.13 , pp. 1257-1264
    • Chen, T.1
  • 3
    • 0033799839 scopus 로고    scopus 로고
    • Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs
    • Krishna, R.; Mayer, L. D. Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharm. Sci. 2000, 11 (4), 265-283.
    • (2000) Eur. J. Pharm. Sci , vol.11 , Issue.4 , pp. 265-283
    • Krishna, R.1    Mayer, L.D.2
  • 4
    • 84867419830 scopus 로고    scopus 로고
    • Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression
    • Nobili, S.; Landini, I.; Mazzei, T.; Mini, E. Overcoming tumor multidrug resistance using drugs able to evade P-glycoprotein or to exploit its expression. Med. Res. Rev. 2012, 32 (6), 1220-1262.
    • (2012) Med. Res. Rev , vol.32 , Issue.6 , pp. 1220-1262
    • Nobili, S.1    Landini, I.2    Mazzei, T.3    Mini, E.4
  • 5
    • 79251517383 scopus 로고    scopus 로고
    • Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP
    • Wang, Y. L.; Yan, Y. L.; Zhou, N. J.; Han, S.; Zhao, J. X.; Cao, C. L.; Lu, Y. H. Mechanism of multidrug resistance of human small cell lung cancer cell line H446/VP. Chin. Med. J. (Engl) 2010, 123 (22), 3299-3303.
    • (2010) Chin. Med. J. (Engl) , vol.123 , Issue.22 , pp. 3299-3303
    • Wang, Y.L.1    Yan, Y.L.2    Zhou, N.J.3    Han, S.4    Zhao, J.X.5    Cao, C.L.6    Lu, Y.H.7
  • 6
    • 0036232692 scopus 로고    scopus 로고
    • Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional Pglycoprotein and MDR1 mRNA
    • Liu, Z. L.; Onda, K.; Tanaka, S.; Toma, T.; Hirano, T.; Oka, K. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional Pglycoprotein and MDR1 mRNA. Cancer Chemother. Pharmacol. 2002, 49 (5), 391-397.
    • (2002) Cancer Chemother. Pharmacol , vol.49 , Issue.5 , pp. 391-397
    • Liu, Z.L.1    Onda, K.2    Tanaka, S.3    Toma, T.4    Hirano, T.5    Oka, K.6
  • 7
    • 33646568511 scopus 로고    scopus 로고
    • Mechanisms and strategies to overcome multiple drug resistance in cancer
    • Ozben, T. Mechanisms and strategies to overcome multiple drug resistance in cancer. FEBS Lett. 2006, 580 (12), 2903-2909.
    • (2006) FEBS Lett , vol.580 , Issue.12 , pp. 2903-2909
    • Ozben, T.1
  • 8
    • 34547650721 scopus 로고    scopus 로고
    • Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells
    • Jin, W.; Scotto, K. W.; Hait, W. N.; Yang, J. M. Involvement of CtBP1 in the transcriptional activation of the MDR1 gene in human multidrug resistant cancer cells. Biochem. Pharmacol. 2007, 74 (6), 851-859.
    • (2007) Biochem. Pharmacol , vol.74 , Issue.6 , pp. 851-859
    • Jin, W.1    Scotto, K.W.2    Hait, W.N.3    Yang, J.M.4
  • 10
    • 0032427211 scopus 로고    scopus 로고
    • Transcriptional regulation of MDR genes
    • Scotto, K. W.; Egan, D. A. Transcriptional regulation of MDR genes. Cytotechnology 1998, 27 (1-3), 257-269.
    • (1998) Cytotechnology , vol.27 , Issue.1-3 , pp. 257-269
    • Scotto, K.W.1    Egan, D.A.2
  • 11
    • 0034936354 scopus 로고    scopus 로고
    • ABC drug transporters: Hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2
    • Kerb, R.; Hoffmeyer, S.; Brinkmann, U. ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. Pharmacogenomics 2001, 2 (1), 51-64.
    • (2001) Pharmacogenomics , vol.2 , Issue.1 , pp. 51-64
    • Kerb, R.1    Hoffmeyer, S.2    Brinkmann, U.3
  • 12
    • 1642523162 scopus 로고    scopus 로고
    • Polymorphisms in human MDR1 (P-glycoprotein): Recent advances and clinical relevance
    • Marzolini, C.; Paus, E.; Buclin, T.; Kim, R. B. Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance. Clin. Pharmacol. Ther. 2004, 75 (1), 13-33.
    • (2004) Clin. Pharmacol. Ther , vol.75 , Issue.1 , pp. 13-33
    • Marzolini, C.1    Paus, E.2    Buclin, T.3    Kim, R.B.4
  • 13
    • 47349110179 scopus 로고    scopus 로고
    • Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition
    • Zhou, S. F. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica 2008, 38 (7-8), 802-832.
    • (2008) Xenobiotica , vol.38 , Issue.7-8 , pp. 802-832
    • Zhou, S.F.1
  • 14
    • 0345688182 scopus 로고    scopus 로고
    • Transcriptional regulation of ABC drug transporters
    • Scotto, K. W. Transcriptional regulation of ABC drug transporters. Oncogene 2003, 22 (47), 7496-7511.
    • (2003) Oncogene , vol.22 , Issue.47 , pp. 7496-7511
    • Scotto, K.W.1
  • 15
    • 55249108934 scopus 로고    scopus 로고
    • Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities
    • Kuo, M. T. Redox Regulation of Multidrug Resistance in Cancer Chemotherapy: Molecular Mechanisms and Therapeutic Opportunities. Antioxid. Redox Signal. 2009, 11 (1), 99-133.
    • (2009) Antioxid. Redox Signal , vol.11 , Issue.1 , pp. 99-133
    • Kuo, M.T.1
  • 16
    • 77958099641 scopus 로고    scopus 로고
    • Multiple drug resistance mechanisms in cancer
    • Baguley, B. C. Multiple drug resistance mechanisms in cancer. Mol. Biotechnol. 2010, 46 (3), 308-316.
    • (2010) Mol. Biotechnol , vol.46 , Issue.3 , pp. 308-316
    • Baguley, B.C.1
  • 17
    • 79959764016 scopus 로고    scopus 로고
    • Toward a better pharmacophore description of P-glycoprotein modulators, based on macrocyclic diterpenes from Euphorbia species
    • Ferreira, R. J.; dos Santos, D. J.; Ferreira, M. J.; Guedes, R. C. Toward a better pharmacophore description of P-glycoprotein modulators, based on macrocyclic diterpenes from Euphorbia species. J. Chem. Inf. Model 2011, 51 (6), 1315-1324.
    • (2011) J. Chem. Inf. Model , vol.51 , Issue.6 , pp. 1315-1324
    • Ferreira, R.J.1    dos Santos, D.J.2    Ferreira, M.J.3    Guedes, R.C.4
  • 18
    • 84862203273 scopus 로고    scopus 로고
    • Insights on PGlycoprotein's Efflux Mechanism Obtained by Molecular Dynamics Simulations
    • Ferreira, R. J.; Ferreira, M. J. U.; dos Santos, D. Insights on PGlycoprotein's Efflux Mechanism Obtained by Molecular Dynamics Simulations. J. Chem. Theory Comput. 2012, 8 (6), 1853-1864.
    • (2012) J. Chem. Theory Comput , vol.8 , Issue.6 , pp. 1853-1864
    • Ferreira, R.J.1    Ferreira, M.J.U.2    dos Santos, D.3
  • 19
    • 73649111071 scopus 로고    scopus 로고
    • Understanding polyspecificity of multidrug ABC transporters: Closing in on the gaps in ABCB1
    • Gutmann, D. A.; Ward, A.; Urbatsch, I. L.; Chang, G.; van Veen, H. W. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1. Trends Biochem. Sci. 2010, 35 (1), 36-42.
    • (2010) Trends Biochem. Sci , vol.35 , Issue.1 , pp. 36-42
    • Gutmann, D.A.1    Ward, A.2    Urbatsch, I.L.3    Chang, G.4    van Veen, H.W.5
  • 20
    • 84855757480 scopus 로고    scopus 로고
    • Chemical Computing Group Inc.: Montreal, QC, Canada
    • Molecular Operating Environment (MOE), 2009. 10, Chemical Computing Group Inc.: Montreal, QC, Canada, 2010.
    • (2010) Molecular Operating Environment
  • 21
    • 33745746815 scopus 로고    scopus 로고
    • Pharmacological strategies for overcoming multidrug resistance
    • Nobili, S.; Landini, I.; Giglioni, B.; Mini, E. Pharmacological strategies for overcoming multidrug resistance. Curr. Drug Targets 2006, 7 (7), 861-879.
    • (2006) Curr. Drug Targets , vol.7 , Issue.7 , pp. 861-879
    • Nobili, S.1    Landini, I.2    Giglioni, B.3    Mini, E.4
  • 22
    • 84860535245 scopus 로고    scopus 로고
    • Three decades of P-gp inhibitors: Skimming through several generations and scaffolds
    • Palmeira, A.; Sousa, E.; Vasconcelos, M. H.; Pinto, M. M. Three decades of P-gp inhibitors: skimming through several generations and scaffolds. Curr. Med. Chem. 2012, 19 (13), 1946-2025.
    • (2012) Curr. Med. Chem , vol.19 , Issue.13 , pp. 1946-2025
    • Palmeira, A.1    Sousa, E.2    Vasconcelos, M.H.3    Pinto, M.M.4
  • 24
    • 84860669151 scopus 로고    scopus 로고
    • Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies
    • Amiri-Kordestani, L.; Basseville, A.; Kurdziel, K.; Fojo, A. T.; Bates, S. E. Targeting MDR in breast and lung cancer: discriminating its potential importance from the failure of drug resistance reversal studies. Drug Resist. Updat. 2012, 15 (1-2), 50-61.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 50-61
    • Amiri-Kordestani, L.1    Basseville, A.2    Kurdziel, K.3    Fojo, A.T.4    Bates, S.E.5
  • 25
    • 51049115157 scopus 로고    scopus 로고
    • Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo
    • Ren, Y.; Wang, Y.; Zhang, Y.; Wei, D. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo. Mol. Pharm. 2008, 5 (4), 579-587.
    • (2008) Mol. Pharm , vol.5 , Issue.4 , pp. 579-587
    • Ren, Y.1    Wang, Y.2    Zhang, Y.3    Wei, D.4
  • 26
    • 79960016661 scopus 로고    scopus 로고
    • Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma
    • Kanwar, J. R.; Singh, N.; Kanwar, R. K. Role of nanomedicine in reversing drug resistance mediated by ATP binding cassette transporters and P-glycoprotein in melanoma. Nanomedicine (Lond) 2011, 6 (4), 701-714.
    • (2011) Nanomedicine (Lond) , vol.6 , Issue.4 , pp. 701-714
    • Kanwar, J.R.1    Singh, N.2    Kanwar, R.K.3
  • 27
    • 84862615963 scopus 로고    scopus 로고
    • Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes
    • Nieto Montesinos, R.; Beduneau, A.; Pellequer, Y.; Lamprecht, A. Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes. J. Control Release 2012, 161 (1), 50-61.
    • (2012) J. Control Release , vol.161 , Issue.1 , pp. 50-61
    • Nieto Montesinos, R.1    Beduneau, A.2    Pellequer, Y.3    Lamprecht, A.4
  • 28
    • 65649147504 scopus 로고    scopus 로고
    • Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: Substrates and/or inhibitors?
    • Hegedus, C.; Ozvegy-Laczka, C.; Szakacs, G.; Sarkadi, B. Interaction of ABC multidrug transporters with anticancer protein kinase inhibitors: substrates and/or inhibitors? Curr. Cancer Drug Targets 2009, 9 (3), 252-272.
    • (2009) Curr. Cancer Drug Targets , vol.9 , Issue.3 , pp. 252-272
    • Hegedus, C.1    Ozvegy-Laczka, C.2    Szakacs, G.3    Sarkadi, B.4
  • 29
    • 84862811607 scopus 로고    scopus 로고
    • Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance
    • Shukla, S.; Chen, Z. S.; Ambudkar, S. V. Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance. Drug Resist. Updat. 2012, 15 (1-2), 70-80.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 70-80
    • Shukla, S.1    Chen, Z.S.2    Ambudkar, S.V.3
  • 31
    • 70349176240 scopus 로고    scopus 로고
    • Is resistance useless? Multidrug resistance and collateral sensitivity
    • Hall, M. D.; Handley, M. D.; Gottesman, M. M. Is resistance useless? Multidrug resistance and collateral sensitivity. Trends Pharmacol. Sci. 2009, 30 (10), 546-556.
    • (2009) Trends Pharmacol. Sci , vol.30 , Issue.10 , pp. 546-556
    • Hall, M.D.1    Handley, M.D.2    Gottesman, M.M.3
  • 32
    • 84860687790 scopus 로고    scopus 로고
    • Immunotherapy: A useful strategy to help combat multidrug resistance
    • Curiel, T. J. Immunotherapy: a useful strategy to help combat multidrug resistance. Drug Resist. Updat. 2012, 15 (1-2), 106-113.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 106-113
    • Curiel, T.J.1
  • 33
    • 84860650725 scopus 로고    scopus 로고
    • Cellular senescence and cancer chemotherapy resistance
    • Gordon, R. R.; Nelson, P. S. Cellular senescence and cancer chemotherapy resistance. Drug Resist. Updat. 2012, 15 (1-2), 123-131.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 123-131
    • Gordon, R.R.1    Nelson, P.S.2
  • 34
    • 84860697028 scopus 로고    scopus 로고
    • The tumor microenvironment is a dominant force in multidrug resistance
    • Correia, A. L.; Bissell, M. J. The tumor microenvironment is a dominant force in multidrug resistance. Drug Resist. Updat. 2012, 15 (1-2), 39-49.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 39-49
    • Correia, A.L.1    Bissell, M.J.2
  • 35
    • 84862821594 scopus 로고    scopus 로고
    • Starvation, detoxification, and multidrug resistance in cancer therapy
    • Lee, C.; Raffaghello, L.; Longo, V. D. Starvation, detoxification, and multidrug resistance in cancer therapy. Drug Resist. Updat. 2012, 15 (1-2), 114-122.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 114-122
    • Lee, C.1    Raffaghello, L.2    Longo, V.D.3
  • 36
    • 78651367221 scopus 로고    scopus 로고
    • ATP-binding cassette transporters in primary central nervous system lymphoma: Decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells
    • Sakata, S.; Fujiwara, M.; Ohtsuka, K.; Kamma, H.; Nagane, M.; Sakamoto, A.; Fujioka, Y. ATP-binding cassette transporters in primary central nervous system lymphoma: decreased expression of MDR1 P-glycoprotein and breast cancer resistance protein in tumor capillary endothelial cells. Oncol. Rep. 2011, 25 (2), 333-339.
    • (2011) Oncol. Rep , vol.25 , Issue.2 , pp. 333-339
    • Sakata, S.1    Fujiwara, M.2    Ohtsuka, K.3    Kamma, H.4    Nagane, M.5    Sakamoto, A.6    Fujioka, Y.7
  • 37
    • 0005582691 scopus 로고    scopus 로고
    • Transcription of the multidrug resistance gene MDR1: A therapeutic target
    • Scotto, K. W.; Johnson, R. A. Transcription of the multidrug resistance gene MDR1: a therapeutic target. Mol. Interv. 2001, 1 (2), 117-125.
    • (2001) Mol. Interv , vol.1 , Issue.2 , pp. 117-125
    • Scotto, K.W.1    Johnson, R.A.2
  • 38
    • 77950192396 scopus 로고    scopus 로고
    • Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin
    • Gao, A.; Wang, X.; Xiang, W.; Liang, H.; Gao, J.; Yan, Y. Reversal of P-glycoprotein-mediated multidrug resistance in vitro by doramectin and nemadectin. J. Pharm. Pharmacol. 2010, 62 (3), 393-399.
    • (2010) J. Pharm. Pharmacol , vol.62 , Issue.3 , pp. 393-399
    • Gao, A.1    Wang, X.2    Xiang, W.3    Liang, H.4    Gao, J.5    Yan, Y.6
  • 39
    • 79961092091 scopus 로고    scopus 로고
    • Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines
    • Cuestas, M. L.; Sosnik, A.; Mathet, V. L. Poloxamines display a multiple inhibitory activity of ATP-binding cassette (ABC) transporters in cancer cell lines. Mol. Pharm. 2011, 8 (4), 1152-1164.
    • (2011) Mol. Pharm , vol.8 , Issue.4 , pp. 1152-1164
    • Cuestas, M.L.1    Sosnik, A.2    Mathet, V.L.3
  • 40
    • 34447506459 scopus 로고    scopus 로고
    • Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin
    • Limtrakul, P.; Chearwae, W.; Shukla, S.; Phisalphong, C.; Ambudkar, S. V. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell Biochem. 2007, 296 (1-2), 85-95.
    • (2007) Mol. Cell Biochem , vol.296 , Issue.1-2 , pp. 85-95
    • Limtrakul, P.1    Chearwae, W.2    Shukla, S.3    Phisalphong, C.4    Ambudkar, S.V.5
  • 41
    • 79954447132 scopus 로고    scopus 로고
    • Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells
    • Donmez, Y.; Akhmetova, L.; Iseri, O. D.; Kars, M. D.; Gunduz, U. Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells. Cancer Chemother. Pharmacol. 2011, 67 (4), 823-828.
    • (2011) Cancer Chemother. Pharmacol , vol.67 , Issue.4 , pp. 823-828
    • Donmez, Y.1    Akhmetova, L.2    Iseri, O.D.3    Kars, M.D.4    Gunduz, U.5
  • 42
    • 84859376472 scopus 로고    scopus 로고
    • Molecular pathways: Regulation and therapeutic implications of multidrug resistance
    • Chen, K. G.; Sikic, B. I. Molecular pathways: regulation and therapeutic implications of multidrug resistance. Clin. Cancer Res. 2012, 18 (7), 1863-1869.
    • (2012) Clin. Cancer Res , vol.18 , Issue.7 , pp. 1863-1869
    • Chen, K.G.1    Sikic, B.I.2
  • 43
    • 0035808413 scopus 로고    scopus 로고
    • 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway
    • Deng, L.; Lin-Lee, Y. C.; Claret, F. X.; Kuo, M. T. 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway. J. Biol. Chem. 2001, 276 (1), 413-420.
    • (2001) J. Biol. Chem , vol.276 , Issue.1 , pp. 413-420
    • Deng, L.1    Lin-Lee, Y.C.2    Claret, F.X.3    Kuo, M.T.4
  • 44
    • 0037150228 scopus 로고    scopus 로고
    • Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling
    • Kuo, M. T.; Liu, Z.; Wei, Y.; Lin-Lee, Y. C.; Tatebe, S.; Mills, G. B.; Unate, H. Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene 2002, 21 (13), 1945-1954.
    • (2002) Oncogene , vol.21 , Issue.13 , pp. 1945-1954
    • Kuo, M.T.1    Liu, Z.2    Wei, Y.3    Lin-Lee, Y.C.4    Tatebe, S.5    Mills, G.B.6    Unate, H.7
  • 45
    • 1542405935 scopus 로고    scopus 로고
    • Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK)
    • Zhang, Y.; Chen, F. Reactive oxygen species (ROS), troublemakers between nuclear factor-kappaB (NF-kappaB) and c-Jun NH(2)-terminal kinase (JNK). Cancer Res. 2004, 64 (6), 1902-1905.
    • (2004) Cancer Res , vol.64 , Issue.6 , pp. 1902-1905
    • Zhang, Y.1    Chen, F.2
  • 46
    • 84862736573 scopus 로고    scopus 로고
    • Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells
    • Cheng, Z.; Yang, N.; Liang, W.; Yan, X.; Li, L.; Pan, L. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Leuk. Lymphoma 2012, 53 (7), 1383-1389.
    • (2012) Leuk. Lymphoma , vol.53 , Issue.7 , pp. 1383-1389
    • Cheng, Z.1    Yang, N.2    Liang, W.3    Yan, X.4    Li, L.5    Pan, L.6
  • 47
    • 17144410320 scopus 로고    scopus 로고
    • Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain
    • Johnson, R. A.; Shepard, E. M.; Scotto, K. W. Differential regulation of MDR1 transcription by the p53 family members. Role of the DNA binding domain. J. Biol. Chem. 2005, 280 (14), 13213-13219.
    • (2005) J. Biol. Chem , vol.280 , Issue.14 , pp. 13213-13219
    • Johnson, R.A.1    Shepard, E.M.2    Scotto, K.W.3
  • 48
    • 79955137781 scopus 로고    scopus 로고
    • Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma
    • Shen, H.; Xu, W.; Luo, W.; Zhou, L.; Yong, W.; Chen, F.; Wu, C.; Chen, Q.; Han, X. Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma. Exp. Hematol. 2011, 39 (5), 558-569.
    • (2011) Exp. Hematol , vol.39 , Issue.5 , pp. 558-569
    • Shen, H.1    Xu, W.2    Luo, W.3    Zhou, L.4    Yong, W.5    Chen, F.6    Wu, C.7    Chen, Q.8    Han, X.9
  • 49
    • 34447321311 scopus 로고    scopus 로고
    • Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein
    • Katayama, K.; Yoshioka, S.; Tsukahara, S.; Mitsuhashi, J.; Sugimoto, Y. Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein. Mol. Cancer Ther. 2007, 6 (7), 2092-2102.
    • (2007) Mol. Cancer Ther , vol.6 , Issue.7 , pp. 2092-2102
    • Katayama, K.1    Yoshioka, S.2    Tsukahara, S.3    Mitsuhashi, J.4    Sugimoto, Y.5
  • 52
    • 76349095132 scopus 로고    scopus 로고
    • Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
    • Semenza, G. L. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010, 29 (5), 625-634.
    • (2010) Oncogene , vol.29 , Issue.5 , pp. 625-634
    • Semenza, G.L.1
  • 53
    • 79957534572 scopus 로고    scopus 로고
    • Targeting hypoxia in cancer therapy
    • Wilson, W. R.; Hay, M. P. Targeting hypoxia in cancer therapy. Nat. Rev. Cancer 2011, 11 (6), 393-410.
    • (2011) Nat. Rev. Cancer , vol.11 , Issue.6 , pp. 393-410
    • Wilson, W.R.1    Hay, M.P.2
  • 54
    • 0142166332 scopus 로고    scopus 로고
    • Targeting HIF-1 for cancer therapy
    • Semenza, G. L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 2003, 3 (10), 721-732.
    • (2003) Nat. Rev. Cancer , vol.3 , Issue.10 , pp. 721-732
    • Semenza, G.L.1
  • 55
    • 84870197971 scopus 로고    scopus 로고
    • Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth
    • Liu, X. Q.; Xiong, M. H.; Shu, X. T.; Tang, R. Z.; Wang, J. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth. Mol. Pharm. 2012, 9 (10), 2863-2874.
    • (2012) Mol. Pharm , vol.9 , Issue.10 , pp. 2863-2874
    • Liu, X.Q.1    Xiong, M.H.2    Shu, X.T.3    Tang, R.Z.4    Wang, J.5
  • 57
    • 69949108875 scopus 로고    scopus 로고
    • Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha
    • Nardinocchi, L.; Puca, R.; Sacchi, A.; Rechavi, G.; Givol, D.; D'Orazi, G. Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha. PLoS One 2009, 4 (8), e6819.
    • (2009) PLoS One , vol.4 , Issue.8
    • Nardinocchi, L.1    Puca, R.2    Sacchi, A.3    Rechavi, G.4    Givol, D.5    D'Orazi, G.6
  • 58
    • 80053049211 scopus 로고    scopus 로고
    • Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1alpha in esophageal cancer cells
    • Zhang, G. J.; Gao, R.; Wang, J. S.; Fu, J. K.; Zhang, M. X.; Jin, X. Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1alpha in esophageal cancer cells. Dis. Esophagus 2011, 24 (7), 481-488.
    • (2011) Dis. Esophagus , vol.24 , Issue.7 , pp. 481-488
    • Zhang, G.J.1    Gao, R.2    Wang, J.S.3    Fu, J.K.4    Zhang, M.X.5    Jin, X.6
  • 59
    • 84862818535 scopus 로고    scopus 로고
    • Recent advances in hypoxiainducible factor (HIF)-1 inhibitors
    • Xia, Y.; Choi, H. K.; Lee, K. Recent advances in hypoxiainducible factor (HIF)-1 inhibitors. Eur. J. Med. Chem. 2012, 49, 24-40.
    • (2012) Eur. J. Med. Chem , vol.49 , pp. 24-40
    • Xia, Y.1    Choi, H.K.2    Lee, K.3
  • 61
    • 0031861729 scopus 로고    scopus 로고
    • Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y
    • Jin, S.; Scotto, K. W. Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y. Mol. Cell Biol. 1998, 18 (7), 4377-4384.
    • (1998) Mol. Cell Biol , vol.18 , Issue.7 , pp. 4377-4384
    • Jin, S.1    Scotto, K.W.2
  • 62
    • 78650176650 scopus 로고    scopus 로고
    • Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation
    • Shi, C. J.; Wang, F.; Ren, M. F.; Mi, Y. J.; Yan, Y. Y.; To, K. K.; Dai, C. L.; Wang, Y. S.; Chen, L. M.; Tong, X. Z.; Liang, Y. J.; Fu, L. W. Up-regulation of ABCB1/P-glycoprotein by escaping promoter hypermethylation indicates poor prognosis in hematologic malignancy patients with and without bone marrow transplantation. Leuk. Res. 2011, 35 (1), 73-79.
    • (2011) Leuk. Res , vol.35 , Issue.1 , pp. 73-79
    • Shi, C.J.1    Wang, F.2    Ren, M.F.3    Mi, Y.J.4    Yan, Y.Y.5    To, K.K.6    Dai, C.L.7    Wang, Y.S.8    Chen, L.M.9    Tong, X.Z.10    Liang, Y.J.11    Fu, L.W.12
  • 63
    • 84860652628 scopus 로고    scopus 로고
    • Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
    • Wilting, R. H.; Dannenberg, J. H. Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance. Drug Resist. Updat. 2012, 15 (1-2), 21-38.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 21-38
    • Wilting, R.H.1    Dannenberg, J.H.2
  • 65
    • 79952932076 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Molecular mechanisms of action and clinical trials as anti-cancer drugs
    • Kim, H. J.; Bae, S. C. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am. J. Transl. Res. 2011, 3 (2), 166-179.
    • (2011) Am. J. Transl. Res , vol.3 , Issue.2 , pp. 166-179
    • Kim, H.J.1    Bae, S.C.2
  • 66
    • 34547864236 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: Molecular mechanisms of action
    • Xu, W. S.; Parmigiani, R. B.; Marks, P. A. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007, 26 (37), 5541-5552.
    • (2007) Oncogene , vol.26 , Issue.37 , pp. 5541-5552
    • Xu, W.S.1    Parmigiani, R.B.2    Marks, P.A.3
  • 67
    • 78649905409 scopus 로고    scopus 로고
    • Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
    • Marks, P. A. Histone deacetylase inhibitors: a chemical genetics approach to understanding cellular functions. Biochim. Biophys. Acta 2010, 1799 (10-12), 717-725.
    • (2010) Biochim. Biophys. Acta , vol.1799 , Issue.10-12 , pp. 717-725
    • Marks, P.A.1
  • 68
    • 77957705615 scopus 로고    scopus 로고
    • UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs
    • Jin, W.; Liu, Y.; Xu, S. G.; Yin, W. J.; Li, J. J.; Yang, J. M.; Shao, Z. M. UHRF1 inhibits MDR1 gene transcription and sensitizes breast cancer cells to anticancer drugs. Breast Cancer Res. Treat. 2010, 124 (1), 39-48.
    • (2010) Breast Cancer Res. Treat , vol.124 , Issue.1 , pp. 39-48
    • Jin, W.1    Liu, Y.2    Xu, S.G.3    Yin, W.J.4    Li, J.J.5    Yang, J.M.6    Shao, Z.M.7
  • 69
    • 79951487862 scopus 로고    scopus 로고
    • Genetic and epigenetic changes in human prostate cancer
    • Koochekpour, S. Genetic and epigenetic changes in human prostate cancer. Iran. Red Crescent Med. J. 2011, 13 (2), 80-98.
    • (2011) Iran. Red Crescent Med. J , vol.13 , Issue.2 , pp. 80-98
    • Koochekpour, S.1
  • 70
    • 35848939204 scopus 로고    scopus 로고
    • Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells
    • Marguerite, V.; Beri-Dexheimer, M.; Ortiou, S.; Gueant, J. L.; Merten, M. Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells. Cell. Physiol. Biochem. 2007, 20 (6), 967-976.
    • (2007) Cell. Physiol. Biochem , vol.20 , Issue.6 , pp. 967-976
    • Marguerite, V.1    Beri-Dexheimer, M.2    Ortiou, S.3    Gueant, J.L.4    Merten, M.5
  • 71
    • 84867441742 scopus 로고    scopus 로고
    • Dysregulation of microRNAs in cancer
    • Chen, P. S.; Su, J. L.; Hung, M. C. Dysregulation of microRNAs in cancer. J. Biomed. Sci. 2012, 19, 90.
    • (2012) J. Biomed. Sci , vol.19 , pp. 90
    • Chen, P.S.1    Su, J.L.2    Hung, M.C.3
  • 72
    • 84872745556 scopus 로고    scopus 로고
    • MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells
    • Ikemura, K.; Yamamoto, M.; Miyazaki, S.; Mizutani, H.; Iwamoto, T.; Okuda, M. MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells. Mol. Pharmacol. 2013, 83 (2), 399-405.
    • (2013) Mol. Pharmacol , vol.83 , Issue.2 , pp. 399-405
    • Ikemura, K.1    Yamamoto, M.2    Miyazaki, S.3    Mizutani, H.4    Iwamoto, T.5    Okuda, M.6
  • 73
    • 84861591908 scopus 로고    scopus 로고
    • Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298
    • Bao, L.; Hazari, S.; Mehra, S.; Kaushal, D.; Moroz, K.; Dash, S. Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am. J. Pathol. 2012, 180 (6), 2490-2503.
    • (2012) Am. J. Pathol , vol.180 , Issue.6 , pp. 2490-2503
    • Bao, L.1    Hazari, S.2    Mehra, S.3    Kaushal, D.4    Moroz, K.5    Dash, S.6
  • 74
    • 84864629063 scopus 로고    scopus 로고
    • Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case
    • Toscano-Garibay, J. D.; Aquino-Jarquin, G. Regulation exerted by miRNAs in the promoter and UTR sequences: MDR1/P-gp expression as a particular case. DNA Cell Biol. 2012, 31 (8), 1358-1364.
    • (2012) DNA Cell Biol , vol.31 , Issue.8 , pp. 1358-1364
    • Toscano-Garibay, J.D.1    Aquino-Jarquin, G.2
  • 75
    • 78650491562 scopus 로고    scopus 로고
    • Resistance may not be futile: MicroRNA biomarkers for chemoresistance and potential therapeutics
    • Allen, K. E.; Weiss, G. J. Resistance may not be futile: microRNA biomarkers for chemoresistance and potential therapeutics. Mol. Cancer Ther. 2010, 9 (12), 3126-3136.
    • (2010) Mol. Cancer Ther , vol.9 , Issue.12 , pp. 3126-3136
    • Allen, K.E.1    Weiss, G.J.2
  • 76
    • 34748865948 scopus 로고    scopus 로고
    • Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells
    • Masuyama, H.; Nakatsukasa, H.; Takamoto, N.; Hiramatsu, Y. Down-regulation of pregnane X receptor contributes to cell growth inhibition and apoptosis by anticancer agents in endometrial cancer cells. Mol. Pharmacol. 2007, 72 (4), 1045-1053.
    • (2007) Mol. Pharmacol , vol.72 , Issue.4 , pp. 1045-1053
    • Masuyama, H.1    Nakatsukasa, H.2    Takamoto, N.3    Hiramatsu, Y.4
  • 77
    • 44149109915 scopus 로고    scopus 로고
    • Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: Studies with anti-human immunodeficiency virus protease inhibitors
    • Gupta, A.; Mugundu, G. M.; Desai, P. B.; Thummel, K. E.; Unadkat, J. D. Intestinal human colon adenocarcinoma cell line LS180 is an excellent model to study pregnane X receptor, but not constitutive androstane receptor, mediated CYP3A4 and multidrug resistance transporter 1 induction: studies with anti-human immunodeficiency virus protease inhibitors. Drug Metab. Dispos. 2008, 36 (6), 1172-1180.
    • (2008) Drug Metab. Dispos , vol.36 , Issue.6 , pp. 1172-1180
    • Gupta, A.1    Mugundu, G.M.2    Desai, P.B.3    Thummel, K.E.4    Unadkat, J.D.5
  • 78
    • 84862813487 scopus 로고    scopus 로고
    • Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters
    • Chen, Y.; Tang, Y.; Guo, C.; Wang, J.; Boral, D.; Nie, D. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. Biochem. Pharmacol. 2012, 83 (8), 1112-1126.
    • (2012) Biochem. Pharmacol , vol.83 , Issue.8 , pp. 1112-1126
    • Chen, Y.1    Tang, Y.2    Guo, C.3    Wang, J.4    Boral, D.5    Nie, D.6
  • 79
    • 84868497825 scopus 로고    scopus 로고
    • Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response
    • Pondugula, S. R.; Mani, S. Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response. Cancer Lett. 2013, 328 (1), 1-9.
    • (2013) Cancer Lett , vol.328 , Issue.1 , pp. 1-9
    • Pondugula, S.R.1    Mani, S.2
  • 80
    • 0042591363 scopus 로고    scopus 로고
    • Transcription factor c-Jun activation represses mdr-1 gene expression
    • Miao, Z. H.; Ding, J. Transcription factor c-Jun activation represses mdr-1 gene expression. Cancer Res. 2003, 63 (15), 4527-4532.
    • (2003) Cancer Res , vol.63 , Issue.15 , pp. 4527-4532
    • Miao, Z.H.1    Ding, J.2
  • 81
    • 73949094806 scopus 로고    scopus 로고
    • Immunosuppressors as multidrug resistance reversal agents
    • Morjani, H.; Madoulet, C. Immunosuppressors as multidrug resistance reversal agents. Methods Mol. Biol. 2010, 596, 433-446.
    • (2010) Methods Mol. Biol , vol.596 , pp. 433-446
    • Morjani, H.1    Madoulet, C.2
  • 82
    • 77951890193 scopus 로고    scopus 로고
    • PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB
    • Bark, H.; Choi, C. H. PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB. Cancer Chemother. Pharmacol. 2010, 65 (6), 1131-1136.
    • (2010) Cancer Chemother. Pharmacol , vol.65 , Issue.6 , pp. 1131-1136
    • Bark, H.1    Choi, C.H.2
  • 83
    • 84860622188 scopus 로고    scopus 로고
    • The proteasome inhibitor bortezomib reverses Pglycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway
    • Wang, H.; Wang, X.; Li, Y.; Liao, A.; Fu, B.; Pan, H.; Liu, Z.; Yang, W. The proteasome inhibitor bortezomib reverses Pglycoprotein-mediated leukemia multi-drug resistance through the NF-kappaB pathway. Pharmazie 2012, 67 (2), 187-192.
    • (2012) Pharmazie , vol.67 , Issue.2 , pp. 187-192
    • Wang, H.1    Wang, X.2    Li, Y.3    Liao, A.4    Fu, B.5    Pan, H.6    Liu, Z.7    Yang, W.8
  • 84
    • 84855208681 scopus 로고    scopus 로고
    • Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-kappaB signaling pathway
    • Yang, H. Y.; Zhao, L.; Yang, Z.; Zhao, Q.; Qiang, L.; Ha, J.; Li, Z. Y.; You, Q. D.; Guo, Q. L. Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-kappaB signaling pathway. Mol. Carcinog. 2012, 51 (2), 185-195.
    • (2012) Mol. Carcinog , vol.51 , Issue.2 , pp. 185-195
    • Yang, H.Y.1    Zhao, L.2    Yang, Z.3    Zhao, Q.4    Qiang, L.5    Ha, J.6    Li, Z.Y.7    You, Q.D.8    Guo, Q.L.9
  • 85
    • 36849021582 scopus 로고    scopus 로고
    • Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway
    • Choi, B. H.; Kim, C. G.; Lim, Y.; Shin, S. Y.; Lee, Y. H. Curcumin down-regulates the multidrug-resistance mdr1b gene by inhibiting the PI3K/Akt/NF kappa B pathway. Cancer Lett. 2008, 259 (1), 111-118.
    • (2008) Cancer Lett , vol.259 , Issue.1 , pp. 111-118
    • Choi, B.H.1    Kim, C.G.2    Lim, Y.3    Shin, S.Y.4    Lee, Y.H.5
  • 86
    • 84865282157 scopus 로고    scopus 로고
    • Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-kappaB signaling pathway in a human breast cancer cell line
    • Lin, X.; Zhang, X.; Wang, Q.; Li, J.; Zhang, P.; Zhao, M.; Li, X. Perifosine downregulates MDR1 gene expression and reverses multidrug-resistant phenotype by inhibiting PI3K/Akt/NF-kappaB signaling pathway in a human breast cancer cell line. Neoplasma 2012, 59 (3), 248-256.
    • (2012) Neoplasma , vol.59 , Issue.3 , pp. 248-256
    • Lin, X.1    Zhang, X.2    Wang, Q.3    Li, J.4    Zhang, P.5    Zhao, M.6    Li, X.7
  • 88
    • 77954633764 scopus 로고    scopus 로고
    • Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMPactivated protein kinase in breast cancer MCF-7/adr cells
    • Hien, T. T.; Kim, H. G.; Han, E. H.; Kang, K. W.; Jeong, H. G. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMPactivated protein kinase in breast cancer MCF-7/adr cells. Mol. Nutr. Food Res. 2010, 54 (7), 918-928.
    • (2010) Mol. Nutr. Food Res , vol.54 , Issue.7 , pp. 918-928
    • Hien, T.T.1    Kim, H.G.2    Han, E.H.3    Kang, K.W.4    Jeong, H.G.5
  • 89
    • 9144271181 scopus 로고    scopus 로고
    • AMPactivated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells
    • Zang, M.; Zuccollo, A.; Hou, X.; Nagata, D.; Walsh, K.; Herscovitz, H.; Brecher, P.; Ruderman, N. B.; Cohen, R. A. AMPactivated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 2004, 279 (46), 47898-47905.
    • (2004) J. Biol. Chem , vol.279 , Issue.46 , pp. 47898-47905
    • Zang, M.1    Zuccollo, A.2    Hou, X.3    Nagata, D.4    Walsh, K.5    Herscovitz, H.6    Brecher, P.7    Ruderman, N.B.8    Cohen, R.A.9
  • 90
    • 34248186686 scopus 로고    scopus 로고
    • Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells
    • Yu, S. T.; Chen, T. M.; Tseng, S. Y.; Chen, Y. H. Tryptanthrin inhibits MDR1 and reverses doxorubicin resistance in breast cancer cells. Biochem. Biophys. Res. Commun 2007, 358 (1), 79-84.
    • (2007) Biochem. Biophys. Res. Commun , vol.358 , Issue.1 , pp. 79-84
    • Yu, S.T.1    Chen, T.M.2    Tseng, S.Y.3    Chen, Y.H.4
  • 91
    • 71949120643 scopus 로고    scopus 로고
    • Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB
    • Zatelli, M. C.; Mole, D.; Tagliati, F.; Minoia, M.; Ambrosio, M. R.; degli Uberti, E. Cyclo-oxygenase 2 modulates chemoresistance in breast cancer cells involving NF-kappaB. Cell. Oncol. 2009, 31 (6), 457-465.
    • (2009) Cell. Oncol , vol.31 , Issue.6 , pp. 457-465
    • Zatelli, M.C.1    Mole, D.2    Tagliati, F.3    Minoia, M.4    Ambrosio, M.R.5    degli Uberti, E.6
  • 92
    • 77951912375 scopus 로고    scopus 로고
    • Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance
    • Liu, B.; Qu, L.; Tao, H. Cyclo-oxygenase 2 up-regulates the effect of multidrug resistance. Cell Biol. Int. 2010, 34 (1), 21-25.
    • (2010) Cell Biol. Int , vol.34 , Issue.1 , pp. 21-25
    • Liu, B.1    Qu, L.2    Tao, H.3
  • 93
    • 33644673861 scopus 로고    scopus 로고
    • Cyclooxygenaseindependent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells
    • Kang, H. K.; Lee, E.; Pyo, H.; Lim, S. J. Cyclooxygenaseindependent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells. Mol. Cancer Ther. 2005, 4 (9), 1358-1363.
    • (2005) Mol. Cancer Ther , vol.4 , Issue.9 , pp. 1358-1363
    • Kang, H.K.1    Lee, E.2    Pyo, H.3    Lim, S.J.4
  • 94
    • 78751615758 scopus 로고    scopus 로고
    • Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib
    • Chen, C.; Shen, H. L.; Yang, J.; Chen, Q. Y.; Xu, W. L. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib. J. Cancer Res. Clin. Oncol. 2011, 137 (1), 9-17.
    • (2011) J. Cancer Res. Clin. Oncol , vol.137 , Issue.1 , pp. 9-17
    • Chen, C.1    Shen, H.L.2    Yang, J.3    Chen, Q.Y.4    Xu, W.L.5
  • 96
    • 41949141389 scopus 로고    scopus 로고
    • Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line
    • Klamt, F.; Passos, D. T.; Castro, M. A.; Gelain, D. P.; Grivicich, I.; Moreira, J. C. Inhibition of MDR1 expression by retinol treatment increases sensitivity to etoposide (VP16) in human neoplasic cell line. Toxicol. In Vitro 2008, 22 (4), 873-878.
    • (2008) Toxicol. In Vitro , vol.22 , Issue.4 , pp. 873-878
    • Klamt, F.1    Passos, D.T.2    Castro, M.A.3    Gelain, D.P.4    Grivicich, I.5    Moreira, J.C.6
  • 97
    • 33646840483 scopus 로고    scopus 로고
    • Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells
    • Shin, S. Y.; Choi, B. H.; Kim, J. R.; Kim, J. H.; Lee, Y. H. Suppression of P-glycoprotein expression by antipsychotics trifluoperazine in adriamycin-resistant L1210 mouse leukemia cells. Eur. J. Pharm. Sci. 2006, 28 (4), 300-306.
    • (2006) Eur. J. Pharm. Sci , vol.28 , Issue.4 , pp. 300-306
    • Shin, S.Y.1    Choi, B.H.2    Kim, J.R.3    Kim, J.H.4    Lee, Y.H.5
  • 98
    • 44449121844 scopus 로고    scopus 로고
    • Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells
    • Zhou, Y. G.; Li, K. Y.; Li, H. D. Effect of the novel antipsychotic drug perospirone on P-glycoprotein function and expression in Caco-2 cells. Eur. J. Clin. Pharmacol. 2008, 64 (7), 697-703.
    • (2008) Eur. J. Clin. Pharmacol , vol.64 , Issue.7 , pp. 697-703
    • Zhou, Y.G.1    Li, K.Y.2    Li, H.D.3
  • 99
    • 54049144205 scopus 로고    scopus 로고
    • Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression
    • Zheng, L. H.; Bao, Y. L.; Wu, Y.; Yu, C. L.; Meng, X.; Li, Y. X. Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADM cells via down-regulation of P-glycoprotein expression. Cancer Lett. 2008, 272 (1), 102-109.
    • (2008) Cancer Lett , vol.272 , Issue.1 , pp. 102-109
    • Zheng, L.H.1    Bao, Y.L.2    Wu, Y.3    Yu, C.L.4    Meng, X.5    Li, Y.X.6
  • 100
    • 77956178476 scopus 로고    scopus 로고
    • Reversal of P-glycoproteinmediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells
    • Xiang, W.; Gao, A.; Liang, H.; Li, C.; Gao, J.; Wang, Q.; Shuang, B.; Zhang, J.; Yan, Y.; Wang, X. Reversal of P-glycoproteinmediated multidrug resistance in vitro by milbemycin compounds in adriamycin-resistant human breast carcinoma (MCF-7/adr) cells. Toxicol. In Vitro 2010, 24 (6), 1474-1481.
    • (2010) Toxicol. In Vitro , vol.24 , Issue.6 , pp. 1474-1481
    • Xiang, W.1    Gao, A.2    Liang, H.3    Li, C.4    Gao, J.5    Wang, Q.6    Shuang, B.7    Zhang, J.8    Yan, Y.9    Wang, X.10
  • 101
    • 33749453246 scopus 로고    scopus 로고
    • Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid
    • Majumder, S.; Dutta, P.; Mukherjee, P.; Datta, E. R.; Efferth, T.; Bhattacharya, S.; Choudhuri, S. K. Reversal of drug resistance in P-glycoprotein-expressing T-cell acute lymphoblastic CEM leukemia cells by copper N-(2-hydroxy acetophenone) glycinate and oxalyl bis (N-phenyl) hydroxamic acid. Cancer Lett. 2006, 244 (1), 16-23.
    • (2006) Cancer Lett , vol.244 , Issue.1 , pp. 16-23
    • Majumder, S.1    Dutta, P.2    Mukherjee, P.3    Datta, E.R.4    Efferth, T.5    Bhattacharya, S.6    Choudhuri, S.K.7
  • 102
    • 77955505177 scopus 로고    scopus 로고
    • A review of trabectedin (ET-743): A unique mechanism of action
    • D'Incalci, M.; Galmarini, C. M. A review of trabectedin (ET-743): a unique mechanism of action. Mol. Cancer Ther. 2010, 9 (8), 2157-2163.
    • (2010) Mol. Cancer Ther , vol.9 , Issue.8 , pp. 2157-2163
    • D'Incalci, M.1    Galmarini, C.M.2
  • 103
    • 72949084796 scopus 로고    scopus 로고
    • Trabectedin: An anticancer drug from the sea
    • Ganjoo, K. N.; Patel, S. R. Trabectedin: an anticancer drug from the sea. Expert. Opin. Pharmacother. 2009, 10 (16), 2735-2743.
    • (2009) Expert. Opin. Pharmacother , vol.10 , Issue.16 , pp. 2735-2743
    • Ganjoo, K.N.1    Patel, S.R.2
  • 104
    • 77952921894 scopus 로고    scopus 로고
    • Wide-spectrum characterization of trabectedin: Biology, clinical activity and future perspectives
    • Vincenzi, B.; Napolitano, A.; Frezza, A. M.; Schiavon, G.; Santini, D.; Tonini, G. Wide-spectrum characterization of trabectedin: biology, clinical activity and future perspectives. Pharmacogenomics 2010, 11 (6), 865-878.
    • (2010) Pharmacogenomics , vol.11 , Issue.6 , pp. 865-878
    • Vincenzi, B.1    Napolitano, A.2    Frezza, A.M.3    Schiavon, G.4    Santini, D.5    Tonini, G.6
  • 105
    • 84880025072 scopus 로고    scopus 로고
    • Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin
    • Takano, M.; Ikeda, Y.; Kudoh, K.; Kita, T.; Sasaki, N.; Kikuchi, Y. Complete remission of recurrent ovarian clear cell carcinoma by chemotherapy with bevacizumab, trabectedin and oxaliplatin. J. Obstet. Gynaecol. Res. 2013, 39 (4), 872-875.
    • (2013) J. Obstet. Gynaecol. Res , vol.39 , Issue.4 , pp. 872-875
    • Takano, M.1    Ikeda, Y.2    Kudoh, K.3    Kita, T.4    Sasaki, N.5    Kikuchi, Y.6
  • 106
    • 84867525162 scopus 로고    scopus 로고
    • Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancer
    • Monk, B. J.; Dalton, H.; Benjamin, I.; Tanovic, A. Trabectedin as a new chemotherapy option in the treatment of relapsed platinum sensitive ovarian cancer. Curr. Pharm. Des. 2012, 18 (25), 3754-3769.
    • (2012) Curr. Pharm. Des , vol.18 , Issue.25 , pp. 3754-3769
    • Monk, B.J.1    Dalton, H.2    Benjamin, I.3    Tanovic, A.4
  • 107
    • 84867533023 scopus 로고    scopus 로고
    • Advances in epithelial ovarian cancer therapy
    • Kroep, J. R. Advances in epithelial ovarian cancer therapy. Curr. Pharm. Des. 2012, 18 (25), 3735-3740.
    • (2012) Curr. Pharm. Des , vol.18 , Issue.25 , pp. 3735-3740
    • Kroep, J.R.1
  • 108
    • 84862099775 scopus 로고    scopus 로고
    • Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma
    • Pink, D.; Bertz-Lepel, J.; Busemann, C.; Bitz, U.; Reichardt, P. Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma. Onkologie 2012, 35 (5), 249-252.
    • (2012) Onkologie , vol.35 , Issue.5 , pp. 249-252
    • Pink, D.1    Bertz-Lepel, J.2    Busemann, C.3    Bitz, U.4    Reichardt, P.5
  • 109
    • 84255167300 scopus 로고    scopus 로고
    • Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma
    • Cioffi, A.; Italiano, A. Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma. Expert Opin. Drug Metab. Toxicol. 2012, 8 (1), 113-122.
    • (2012) Expert Opin. Drug Metab. Toxicol , vol.8 , Issue.1 , pp. 113-122
    • Cioffi, A.1    Italiano, A.2
  • 111
    • 84860688652 scopus 로고    scopus 로고
    • Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1
    • Gillet, J. P.; Gottesman, M. M. Overcoming multidrug resistance in cancer: 35 years after the discovery of ABCB1. Drug Resist. Updat. 2012, 15 (1-2), 2-4.
    • (2012) Drug Resist. Updat , vol.15 , Issue.1-2 , pp. 2-4
    • Gillet, J.P.1    Gottesman, M.M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.